STRO 8-K 2026-08-12

SUTRO BIOPHARMA, INC. (STRO) 8-K dated 2026-08-12 — accession 0001193125-26-345733. This URL is the filing, not the STRO hub.

SUTRO BIOPHARMA, INC. (STRO) is a biotechnology company listed on NASDAQ.

SUTRO BIOPHARMA, INC. filed a 8-K on 2026-08-12. Accession 0001193125-26-345733.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported STRO revenue for 2026-06-30 was $24.4M. Net income was -$77.0M. Revenue was up 67.7% from 2026-03-31 to 2026-06-30. STRO currently screens at market cap $470.8M.

Not investment advice. The STRO SEC hub lists recent forms. The stock page is the research view.